logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sheeba K. Thomas

The University of Texas MD Anderson Cancer Center
H指数:32
被引数:4,422

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

作者更正：FcRH5×CD3 双特异性抗体 cevostamab 在复发或难治性多发性骨髓瘤中的研究：一项1期临床试验

Nature Medicine
IF50
2026-10-200
OAAI
Adam D. Cohen; Joshua Richter; Suzanne Trudel; Alexander Lesokhin; Jacob P. Laubach; Sheeba K. Thomas; Simon J. Harrison; Luciano J. Costa; Andrew Spencer; Rafael Fonseca; Peter A. Forsberg; Jesus G. Berdeja; Rayan Kaedbey; Nizar J. Bahlis; Paula Rodriguez-Otero; Maria-Victoria Mateos; Tulika Tyagi; Divya Samineni; Wenyu Liu; Rin Nakamura; Voleak Choeurng; Chihunt Wong; James Cooper; Amrita Krishnan
Daratumumab ± pomalidomide maintenance after salvage autologous transplantation in relapsed multiple myeloma: a phase 2 study

在复发多发性骨髓瘤中，自体移植后使用达鲁单抗±泊马利度胺进行维持治疗：一项2期研究

Blood Cancer Journal
IF11.6
2026-09-260
OAAI
Oren Pasvolsky; Bruno Almeida Costa; Yosra M. Aljawai; Krina K. Patel; Qaiser Bashir; Dawen Sui; Samer A. Srour; Mark R. Tanner; Uday R. Popat; Neeraj Y. Saini; Chitra Hosing; Jeremy L. Ramdial; Hans C. Lee; Gregory P. Kaufman; Sheeba K. Thomas; Donna M. Weber; Melody Becnel; Guilin Tang; Robert Z. Orlowski; Richard E. Champlin; Yago Nieto; Elizabeth J. Shpall; Muzaffar H. Qazilbash
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma

卡非佐米、来那度胺和地塞米松（KRd）与硼替佐米、来那度胺和地塞米松（VRd）在自体造血干细胞移植/移植前诱导治疗新诊断多发性骨髓瘤的比较

British Journal of Haematology
IF3.8
2026-08-200
PRE
Curtis Marcoux; Denái R. Milton; Mark R. Tanner; Qaiser Bashir; Samer Srour; Neeraj Saini; Paul Lin; Jeremy Ramdial; Yago Nieto; Saqib Ahmed; Rita E. Deeba; Guilin Tang; Yosra Aljawai; Hans C. Lee; Krina K. Patel; Mahmoud R. Gaballa; Partow Kebriaei; Sheeba K. Thomas; Robert Z. Orlowski; Richard E. Champlin; Elizabeth J. Shpall; Muzaffar H. Qazilbash; Oren Pasvolsky
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

FcRH5×CD3双特异性抗体塞沃司单抗在复发或难治性多发性骨髓瘤中的应用：一项I期临床试验

Nature Medicine
IF50
2026-07-220
OAAI
Adam D. Cohen; Joshua Richter; Suzanne Trudel; Alexander Lesokhin; Jacob P. Laubach; Sheeba K. Thomas; Simon J. Harrison; Luciano J. Costa; Andrew Spencer; Rafael Fonseca; Peter A. Forsberg; Jesus G. Berdeja; Rayan Kaedbey; Nizar J. Bahlis; Paula Rodriguez-Otero; Maria-Victoria Mateos; Tulika Tyagi; Divya Samineni; Wenyu Liu; Rin Nakamura; Voleak Choeurng; Chihunt Wong; James Cooper; Amrita Krishnan
D-VRD induction and autologous transplant in patients ≥70 years

D-VRD诱导和自体移植在≥70岁患者中的应用

Blood Cancer Journal
IF11.6
2026-06-050
OAAI
Oren Pasvolsky; Curtis Marcoux; Denái R. Milton; Mark R. Tanner; Muhammad Bilal Islam; Qaiser Bashir; Samer Srour; Neeraj Saini; Paul Lin; Jeremy Ramdial; Yago Nieto; Guilin Tang; Yosra Aljawai; Asad A. Haider; Hans C. Lee; Krina K. Patel; Partow Kebriaei; Sheeba K. Thomas; Robert Z. Orlowski; Richard E. Champlin; Elizabeth J. Shpall; Muzaffar H. Qazilbash
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up

奥加曲沙在瓦尔登斯特伦巨球蛋白血症中，5年随访显示持久应答

Blood Advances
IF7.1
2026-04-170
OAAI
Roger G. Owen; Helen McCarthy; Shirley D’Sa; Sheeba K. Thomas; Olivier Tournilhac; Francesco Forconi; Marie José Kersten; Pier Luigi Zinzani; Sunil Iyengar; Jaimal Kothari; Monique C. Minnema; Efstathios Kastritis; Bruce D. Cheson; Harriet S. Walter; Daniel Greenwald; Roser Calvo; Yi Li; Simon Rule; Richard R. Furman
Association of genetic ancestry with outcomes and toxicity of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma

遗传血统与复发/难治性多发性骨髓瘤患者接受伊decabtagene vicleucel治疗后结局和毒性的关联

Blood Cancer Journal
IF11.6
2026-04-130
OAAI
Christen M. Dillard; Hans Lee; Nilesh Kalariya; Naveen Subramanian; Oren Pasvolsky; Christopher Ferreri; Mahmoud Gaballa; Sheeba K. Thomas; Donna M. Weber; Melody Becnel; Gregory Kaufman; Muzaffar Qazilbash; Robert Z. Orlowski; Michelle A. T. Hildebrandt; Krina K. Patel
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma

延迟或挽救性自体造血干细胞移植治疗多发性骨髓瘤的结果

Bone Marrow Transplantation
IF5.2
2025-12-050
PRE
Oren Pasvolsky; Curtis Marcoux; Denái R. Milton; Asad A. Haider; Mark R. Tanner; Qaiser Bashir; Samer Srour; Neeraj Saini; Portia Smallbone; Paul Lin; Jeremy Ramdial; Yago Nieto; Ali H. Mohamedi; Umer R. Siddiqui; Abdullah Jamil; Guilin Tang; Yosra Aljawai; Hans C. Lee; Krina K. Patel; Partow Kebriaei; Sheeba K. Thomas; Robert Z. Orlowski; Richard E. Champlin; Elizabeth J. Shpall; Muzaffar H. Qazilbash
Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy

Waldenström巨球蛋白血症患者停止Bruton酪氨酸激酶抑制剂（BTKi）治疗后的长期结局及治疗模式

Blood Cancer Journal
IF11.6
2025-12-030
OAAI
Karan L. Chohan; Lorenzo Gensini; Sherif Seif; Xiaowen Sun; Lei Feng; Melody R. Becnel; Mahmoud M. Gaballa; Hans C. Lee; Oren Pasvolsky; Krina K. Patel; J. Christine Ye; Donna M. Weber; Robert Z. Orlowski; Sheeba K. Thomas
Outcomes of Patients with Multiple Myeloma with deletion 1p Following Autologous Stem Cell Transplant

多发性骨髓瘤患者伴有1p缺失行自体干细胞移植后的结局

Transplantation and Cellular Therapy
IF4.4
2025-08-050
PRE
Curtis Marcoux; Denái R. Milton; Mark R. Tanner; Qaiser Bashir; Samer Srour; Neeraj Saini; Paul Lin; Ashka Patel; Hina N. Khan; Jeremy Ramdial; Yago Nieto; Guilin Tang; Asad Haider; Yosra Aljawai; Partow Kebriaei; Hans C. Lee; Christine Ye; Krina K. Patel; Sheeba K. Thomas; Robert Z. Orlowski; Richard E. Champlin; Elizabeth J. Shpall; Muzaffar H. Qazilbash; Oren Pasvolsky
Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis

复发/难治性淋巴浆细胞样淋巴瘤/华氏巨球蛋白血症患者接受维奈克拉治疗后的结局：一项多中心回顾性分析

BLOOD CANCER JOURNAL
IF11.6
2025-04-150
OA
Sawalha, Y.; Sarosiek, S.; Welkie, R. L.; Seif, S.; Thapa, S.; Zanwar, S.; Cahill, K.; Treitman, R.; Shah, H.; Arora, S.; Pongas, G.; Winter, A.; Major, A.; Riedell, P. A.; Palomba, M. L.; Kapoor, P.; Grajales-Cruz, A.; Shain, K. H.; Thomas, S. K.; Castillo, J. J.
Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets

单细胞分析识别了恶性浆细胞的骨髓瘤病理生物学介质和潜在靶点

CELL REPORTS MEDICINE
IF10.6
2025-02-010
OAAI
Rueda, Luz Yurany Moreno; Wang, Hua; Akagi, Keiko; Dang, Minghao; Vora, Amishi; Qin, Li; Lee, Hans C.; Patel, Krina K.; Lin, Pei; Mery, David E.; Zhan, Fenghuang; Shaughnessy Jr, John D.; Yi, Qing; Song, Yang; Jiang, Bo; Gillison, Maura L.; Thomas, Sheeba K.; Weber, Donna M.; Diao, Lixia; Wang, Jing; Kuiatse, Isere; Manasanch, Elisabet E.; Symer, David E.; Orlowski, Robert Z.
Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17p
TRANSPLANTATION AND CELLULAR THERAPY
IF4.4
2025-01-010
PRE
Marcoux, Curtis; Pasvolsky, Oren; Milton, Denaii R.; Tanner, Mark R.; Bashir, Qaiser; Srour, Samer; Saini, Neeraj; Lin, Paul; Ramdial, Jeremy; Nieto, Yago; Tang, Guilin; Lee, Hans C.; Patel, Krina K.; Kebriaei, Partow; Ahmed, Amna; Aljawai, Yosra; Thomas, Sheeba K.; Orlowski, Robert Z.; Shpall, Elizabeth J.; Champlin, Richard E.; Qazilbash, Muzaffar H.
Impact of Age on Autologous Stem Cell Transplantation Outcomes for AL Amyloidosis

年龄对AL淀粉样变性自体干细胞移植结局的影响

BLOOD
IF23.1
2024-11-050
PRE
Sami, Sophiya S.; Bashir, Qaiser; Saini, Neeraj Y.; Aljawai, Yosra M.; Hosing, Chitra; Popat, Uday; Becnel, Melody R.; Kaufman, Gregory P.; Thomas, Sheeba K.; Weber, Donna M.; Orlowski, Robert Z.; Champlin, Richard E.; Shpall, Elizabeth J.; Qazilbash, Muzaffar H.; Srour, Samer A.
Personalized Neoantigen Peptide Vaccine with or without Lenalidomide for Patients with Intermediate or High Risk Smoldering Multiple Myeloma (SMM) to Prevent Progression to Multiple Myeloma (MM)

个性化新抗原肽疫苗联合或不联合来那度胺用于中危或高危冒烟型多发性骨髓瘤(SMM)患者，以预防进展为多发性骨髓瘤(MM)

BLOOD
IF23.1
2024-11-050
PRE
Patel, Krina K.; Manasanch, Elisabet E.; Lee, Hans C.; Ye, J. Christine; Thomas, Sheeba K.; Weber, Donna M.; Becnel, Melody R.; Gaballa, Mahmoud R.; Bansal, Hima; Berkova, Zuzana; Neelapu, Sattva S.; Haymaker, Cara L.; Dang, Minghao; Wang, Linghua; Lizee, Greg; Orlowski, Robert Z.
Second Line Treatment in Patients with Multiple Myeloma Progressing after Bortezomib, Lenalidomide, Dexamethasone Induction, Autologous Transplant and Lenalidomide Maintenance

二线治疗在经硼替佐米、来那度胺、地塞米松诱导，自体移植和来那度胺维持治疗后进展的多发性骨髓瘤患者中的应用

BLOOD
IF23.1
2024-11-050
PRE
Pasvolsky, Oren; Milton, Denai R.; Tanner, Mark R.; Bashir, Qaiser; Srour, Samer A.; Saini, Neeraj Y.; Lin, Paul; Siddiqui, Umer R.; Khan, Hina N.; Ramdial, Jeremy; Nieto, Yago; Tang, Guilin; Lakhani, Kiran; Aljawai, Yosra M.; Kebriaei, Partow; Lee, Hans C.; Patel, Krina K.; Thomas, Sheeba K.; Orlowski, Robert Z.; Shpall, Elizabeth J.; Champlin, Richard E.; Qazilbash, Muzaffar H.

研究方向

暂未获取到该数据
R
Robert Z. Orlowski
H 指数:101论文数:1,147被引数:5.3万
H
Hans C. Lee
H 指数:50论文数:606被引数:1.1万
K
Krina K. Patel
H 指数:28论文数:546被引数:4,666
D
Donna M. Weber
H 指数:36论文数:342被引数:5,631
M
Muzaffar H. Qazilbash
H 指数:52论文数:843被引数:1.2万
R
Richard E. Champlin
H 指数:147论文数:2,081被引数:7.6万
Q
Qaiser Bashir
H 指数:37论文数:546被引数:5,879
Y
Yago Nieto
H 指数:54论文数:718被引数:1.4万
O
Oren Pasvolsky
H 指数:17论文数:296被引数:1,495
S
Samer A. Srour
H 指数:25论文数:404被引数:2,249